Your browser doesn't support javascript.
loading
Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia.
McMahon, Christine M; Canaani, Jonathan; Rea, Bryan; Sargent, Rachel L; Qualtieri, Julianne N; Watt, Christopher D; Morrissette, Jennifer J D; Carroll, Martin; Perl, Alexander E.
Afiliación
  • McMahon CM; Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA.
  • Canaani J; Hematology Division, Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Israel.
  • Rea B; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Sargent RL; Janssen Research and Development, Spring House, PA.
  • Qualtieri JN; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Watt CD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Morrissette JJD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; and.
  • Carroll M; Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA.
  • Perl AE; Philadelphia Veterans Affairs Medical Center, Philadelphia, PA.
Blood Adv ; 3(10): 1581-1585, 2019 05 28.
Article en En | MEDLINE | ID: mdl-31122910

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Leucemia Mieloide Aguda / Tirosina Quinasa 3 Similar a fms / Compuestos de Anilina Límite: Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazinas / Leucemia Mieloide Aguda / Tirosina Quinasa 3 Similar a fms / Compuestos de Anilina Límite: Humans Idioma: En Revista: Blood Adv Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos